Bergmann Manuela M, Rehm Jürgen, Klipstein-Grobusch Kerstin, Boeing Heiner, Schütze Madlen, Drogan Dagmar, Overvad Kim, Tjønneland Anne, Halkjær Jytte, Fagherazzi Guy, Boutron-Ruault Marie-Christine, Clavel-Chapelon Françoise, Teucher Birgit, Kaaks Rudolph, Trichopoulou Antonia, Benetou Vassiliki, Trichopoulos Dimitrios, Palli Domenico, Pala Valeria, Tumino Rosario, Vineis Paolo, Beulens Joline Wj, Redondo Maria Luisa, Duell Eric J, Molina-Montes Esther, Navarro Carmen, Barricarte Aurelio, Arriola Larraitz, Allen Naomi E, Crowe Francesca L, Khaw Kay-Tee, Wareham Nick, Romaguera Dora, Wark Petra A, Romieu Isabelle, Nunes Luciana, Riboli Elio, Ferrari Pietro
German Institute of Human Nutrition Potsdam-Rehbrücke, Division of Epidemiology, Nuthetal, Germany, Centre for Addiction and Mental Health (CAMH), Toronto, Canada, Institute for Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany, Julius Center for Health Sciences and Primary Care University Medical Center Utrecht, Utrecht, The Netherlands, Division of Epidemiology and Biostatistics, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa, Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark, Danish Cancer Society Research Center, Copenhagen, Denmark, Nutrition, Hormones and Women's Health, CESP Centre for Research in Epidemiology and Public Health, and Paris South University, Villejuif, France, Department of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany, WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece, Hellenic Health Foundation, Athens, Greece, Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA, Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece, Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy, Nutritional Epidemiology Unit Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy, Cancer Registry and Histopathology Unit, Civile-M.P. Arezzo Hospital, Ragusa, Italy, MRC/HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, UK, HuGeF Foundation, Torino, Italy, Public Health Directorate, Asturias, Spain, Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, Barcelona, Spain, Andalusian School of Public Health and CIBER de Epidemiología y Salud Pública, Granada, Spain, Departmen
Int J Epidemiol. 2013 Dec;42(6):1772-90. doi: 10.1093/ije/dyt154.
There is limited evidence for an association between the pattern of lifetime alcohol use and cause-specific risk of death.
Multivariable hazard ratios were estimated for different causes of death according to patterns of lifetime alcohol consumption using a competing risks approach: 111 953 men and 268 442 women from eight countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study were included. Self-reported alcohol consumption at ages 20, 30, 40 or 50 years and at enrollment were used for the analysis; 26 411 deaths were observed during an average of 12.6 years of follow-up.
The association between lifetime alcohol use and death from cardiovascular diseases was different from the association seen for alcohol-related cancers, digestive, respiratory, external and other causes. Heavy users (>5 drinks/day for men and >2.5 drinks/day for women), regardless of time of cessation, had a 2- to 5-times higher risk of dying due to alcohol-related cancers, compared with subjects with lifetime light use (≤1 and ≤0.5 drink/week for men and women, respectively). Compared with lifetime light users, men who used <5 drinks/day throughout their lifetime had a 24% lower cardiovascular disease mortality (95% confidence interval 2-41). The risk of death from coronary heart disease was also found to be 34-46% lower among women who were moderate to occasionally heavy alcohol users compared with light users. However, this relationship was only evident among men and women who had no chronic disease at enrollment.
Limiting alcohol use throughout life is associated with a lower risk of death, largely due to cardiovascular disease but also other causes. However, the potential health benefits of alcohol use are difficult to establish due to the possibility of selection bias and competing risks related to diseases occurring later in life.
终生饮酒模式与特定病因死亡风险之间的关联证据有限。
采用竞争风险方法,根据终生饮酒模式估算不同死因的多变量风险比:纳入了来自八个国家参与欧洲癌症与营养前瞻性调查(EPIC)研究的111953名男性和268442名女性。分析使用了20岁、30岁、40岁或50岁以及入组时自我报告的饮酒量;在平均12.6年的随访期间观察到26411例死亡。
终生饮酒与心血管疾病死亡之间的关联不同于与酒精相关癌症、消化系统、呼吸系统、外部及其他病因的关联。重度饮酒者(男性>5杯/天,女性>2.5杯/天),无论戒酒时间如何,与终生轻度饮酒者(男性和女性分别≤1杯/周和≤0.5杯/周)相比,因酒精相关癌症死亡的风险高出2至5倍。与终生轻度饮酒者相比,终生每天饮酒<5杯的男性心血管疾病死亡率低24%(95%置信区间2 - 41)。与轻度饮酒者相比,中度至偶尔重度饮酒的女性冠心病死亡风险也低34 - 46%。然而,这种关系仅在入组时无慢性病的男性和女性中明显。
终生限制饮酒与较低的死亡风险相关,主要是由于心血管疾病,但也包括其他病因。然而,由于存在选择偏倚以及与晚年发生的疾病相关的竞争风险,饮酒对健康的潜在益处难以确定。